The microbiome’s role in health and diseases: Emerging therapeutic interventions and challenges

The human microbiome, the diverse collection of microorganisms that inhabit our body, is essential for our health and well-being.However, when the microbiome is disturbed or imbalanced, known as dysbiosis, it can trigger or worsen various diseases, such as gastrointestinal, metabolic, cardiovascular, and neurological disorders.The latest research underscores the significant influence of the microbiome, particularly the gut microbiome, on health and disease, affecting various aspects of physiology and immunity.Emerging therapies targeting the microbiome, including fecal microbiota transplantation (FMT), engineered bacteria, and microbiome-derived drugs, are also spotlighted, reflecting their potential in advancing medical treatments.FMT, which involves transferring fecal matter from a healthy donor to a patient, has proven effective in treating recurrent Clostridium difficile infections and is being tested for other indications.Engineered bacteria are designed to deliver specific drugs or modulate the immune system in the gut.Microbiome derived drugs are molecules produced by the microbiome that have therapeutic potential.However, translating microbiome research into clinical practice faces many challenges, such as the variability of the microbiome among individuals, the difficulty of producing and standardizing live bacterial products, and the regulatory issues involved.To overcome these challenges, we need a multidisciplinary approach that combines microbiology, immunology, genomics, and clinical science.This article emphasizes the importance of the microbiome in human health and disease and showcases the promise of microbiomebased therapies, while acknowledging the obstacles that need to be addressed to achieve their clinical application.